TROSPIUM CHLORIDE

TROSPIUM CHLORIDE was reported 2767 times

TROSPIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENITAL INFECTION VIRAL 13 0.5652
1 FEMORAL HERNIA INCARCERATED 26 0.3611
2 LYMPHATIC FISTULA 26 0.2600
3 ENDOMETRIAL CANCER STAGE III 11 0.1392
4 DISSEMINATED ENTEROVIRAL INFECTION 2 0.1111
5 K-RAS GENE MUTATION 11 0.1038
6 PANCREATIC STEATOSIS 25 0.0919
7 COMA URAEMIC 2 0.0909
8 WOUND INFECTION PSEUDOMONAS 26 0.0831
9 BLADDER TRABECULATION 6 0.0741
10 B-LYMPHOCYTE ABNORMALITIES 9 0.0629
11 B-LYMPHOCYTE COUNT INCREASED 9 0.0484
12 GENITAL TRACT INFLAMMATION 9 0.0452
13 PULMONARY HAEMATOMA 4 0.0342
14 OXIDATIVE STRESS 3 0.0319
15 JUVENILE MYOCLONIC EPILEPSY 2 0.0317
16 VULVOVAGINITIS 9 0.0306
17 SACROILIAC JOINT DYSFUNCTION 4 0.0301
18 DISTAL INTESTINAL OBSTRUCTION SYNDROME 10 0.0297
19 PORTAL FIBROSIS 6 0.0280
20 TROPONIN ABNORMAL 3 0.0244
21 ARTERIAL HAEMORRHAGE 26 0.0227
22 PARKINSONIAN REST TREMOR 4 0.0212
23 DIABETIC KETOSIS 8 0.0211
24 SEROMA 26 0.0204
25 AORTIC VALVE STENOSIS 33 0.0185
26 POSTMORTEM BLOOD DRUG LEVEL INCREASED 6 0.0161
27 GENITAL HERPES 22 0.0144
28 AORTIC VALVE CALCIFICATION 7 0.0136
29 SICK LEAVE 3 0.0133
30 ENDOTHELIAL DYSFUNCTION 3 0.0130
31 SARS-COV-2 ANTIBODY TEST NEGATIVE 6 0.0125
32 FLAT ANTERIOR CHAMBER OF EYE 2 0.0112
33 EJACULATION DELAYED 6 0.0108
34 LARYNGEAL INFLAMMATION 2 0.0106
35 PRURIGO 9 0.0098
36 SUPERFICIAL VEIN THROMBOSIS 8 0.0095
37 TACHYARRHYTHMIA 23 0.0092
38 CATHETER SITE IRRITATION 3 0.0090
39 FAECALOMA 49 0.0089
40 ACQUIRED OESOPHAGEAL WEB 3 0.0088
41 AORTIC ARTERIOSCLEROSIS 22 0.0085
42 LEUKOCYTURIA 7 0.0085
43 WOUND DEHISCENCE 28 0.0083
44 MOTOR NEURONE DISEASE 4 0.0082
45 PHIMOSIS 6 0.0081
46 LIPID METABOLISM DISORDER 3 0.0078
47 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 3 0.0078
48 HEPATIC CYST 26 0.0076
49 KLEBSIELLA URINARY TRACT INFECTION 2 0.0075
50 BALANOPOSTHITIS 6 0.0073
51 TISSUE INJURY 3 0.0069
52 OVARIAN CANCER RECURRENT 11 0.0068
53 CATHETER SITE CELLULITIS 2 0.0068
54 MITOCHONDRIAL CYTOPATHY 3 0.0068
55 UPPER AIRWAY OBSTRUCTION 6 0.0068
56 DIVERTICULUM INTESTINAL 29 0.0066
57 BLADDER SPASM 12 0.0064
58 PENILE SIZE REDUCED 6 0.0063
59 PIGMENTARY MACULOPATHY 3 0.0062
60 INFLAMMATORY MARKER INCREASED 30 0.0060
61 ENTEROSTOMY 2 0.0059
62 HEART VALVE STENOSIS 2 0.0055
63 PRURITUS GENITAL 13 0.0055
64 CYSTITIS NONINFECTIVE 7 0.0052
65 RETINAL PIGMENTATION 4 0.0051
66 ANTICHOLINERGIC SYNDROME 8 0.0050
67 DEATH OF RELATIVE 2 0.0049
68 APLASTIC ANAEMIA 25 0.0048
69 MEDICATION OVERUSE HEADACHE 4 0.0047
70 CARDIAC DISCOMFORT 9 0.0045
71 SENSE OF OPPRESSION 5 0.0042
72 GASTRIC VARICES 2 0.0042
73 INFUSION SITE HAEMATOMA 2 0.0042
74 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
75 POSTOPERATIVE WOUND INFECTION 28 0.0041
76 BLOOD URIC ACID DECREASED 2 0.0041
77 GROIN PAIN 36 0.0041
78 PSYCHIATRIC DECOMPENSATION 8 0.0041
79 BLUNTED AFFECT 3 0.0041
80 LEFT VENTRICULAR FAILURE 14 0.0041
81 BACTERIAL TEST POSITIVE 9 0.0040
82 MICTURITION FREQUENCY DECREASED 3 0.0040
83 INFUSION SITE ABSCESS 2 0.0040
84 ATRIOVENTRICULAR BLOCK SECOND DEGREE 12 0.0040
85 REACTION TO EXCIPIENT 9 0.0039
86 INFUSION SITE CELLULITIS 2 0.0038
87 HYPERKINESIA 8 0.0038
88 STRESS URINARY INCONTINENCE 4 0.0037
89 FRACTURE PAIN 2 0.0037
90 B-LYMPHOCYTE COUNT DECREASED 5 0.0037
91 ERYTHRODERMIC PSORIASIS 3 0.0036
92 DRY AGE-RELATED MACULAR DEGENERATION 4 0.0036
93 ESCHERICHIA INFECTION 29 0.0035
94 CRANIOFACIAL FRACTURE 3 0.0035
95 KIDNEY FIBROSIS 6 0.0035
96 CYSTOCELE 3 0.0035
97 HEPATITIS TOXIC 9 0.0035
98 ENTERAL NUTRITION 2 0.0034
99 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 4 0.0033
100 NEUROGENIC BLADDER 7 0.0033
101 DEEP BRAIN STIMULATION 2 0.0033
102 MUCOSAL EROSION 3 0.0033
103 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
104 TRICUSPID VALVE INCOMPETENCE 25 0.0031
105 ANURIA 27 0.0031
106 HYPERTONIC BLADDER 9 0.0031
107 ANISOCYTOSIS 2 0.0030
108 HALLUCINATION, TACTILE 2 0.0030
109 MITRAL VALVE INCOMPETENCE 34 0.0030
110 CATARACT NUCLEAR 2 0.0030
111 HYDRONEPHROSIS 22 0.0029
112 MICTURITION DISORDER 10 0.0029
113 JOINT DISLOCATION 30 0.0028
114 HAEMARTHROSIS 25 0.0028
115 FACIAL BONES FRACTURE 10 0.0028
116 BACTERIAL DISEASE CARRIER 2 0.0027
117 ACCOMMODATION DISORDER 2 0.0027
118 CORNEAL TRANSPLANT 2 0.0026
119 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
120 SUBILEUS 5 0.0024
121 HIATUS HERNIA 31 0.0024
122 INFECTED BITE 2 0.0024
123 URINE ANALYSIS ABNORMAL 7 0.0023
124 THYROIDECTOMY 4 0.0023
125 EXPOSURE VIA FATHER 3 0.0023
126 SKIN ODOUR ABNORMAL 9 0.0023
127 FREEZING PHENOMENON 8 0.0022
128 CARDIOGENIC SHOCK 31 0.0022
129 CHRONIC FATIGUE SYNDROME 3 0.0022
130 GENITAL RASH 3 0.0021
131 CEREBELLAR ATAXIA 2 0.0021
132 PLANTAR FASCIITIS 7 0.0021
133 DISCOLOURED VOMIT 2 0.0021
134 ON AND OFF PHENOMENON 11 0.0020
135 URINARY TRACT INFECTION BACTERIAL 5 0.0020
136 AGE-RELATED MACULAR DEGENERATION 3 0.0020
137 AUTONOMIC NEUROPATHY 2 0.0020
138 BLADDER DYSFUNCTION 2 0.0019
139 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
140 MUSCLE SPASTICITY 23 0.0019
141 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
142 AUTOIMMUNE THYROIDITIS 7 0.0018
143 INFUSION SITE MASS 2 0.0018
144 PARESIS 4 0.0018
145 DRUG EFFECT VARIABLE 2 0.0018
146 URINARY RETENTION 58 0.0017
147 OSTEOPENIA 26 0.0017
148 THROMBOPHLEBITIS 6 0.0017
149 INCONTINENCE 18 0.0017
150 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
151 URINE FLOW DECREASED 4 0.0017
152 ESCHERICHIA TEST POSITIVE 2 0.0017
153 MYELODYSPLASTIC SYNDROME 24 0.0017
154 INFUSION SITE WARMTH 2 0.0016
155 CORONARY ARTERY STENOSIS 8 0.0016
156 CORONARY ARTERY DISEASE 47 0.0016
157 IMMUNE RECONSTITUTION SYNDROME 2 0.0015
158 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
159 CELL DEATH 3 0.0015
160 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
161 INTESTINAL DILATATION 2 0.0015
162 PYELONEPHRITIS 13 0.0015
163 ERUCTATION 29 0.0015
164 PULMONARY HYPERTENSION 31 0.0015
165 JOINT INSTABILITY 2 0.0014
166 SLEEP DEFICIT 3 0.0014
167 METASTATIC NEOPLASM 6 0.0014
168 ANGINA UNSTABLE 9 0.0014
169 METABOLIC DISORDER 8 0.0014
170 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
171 VARICOSE VEIN 7 0.0014
172 CONJUNCTIVITIS ALLERGIC 2 0.0013
173 APRAXIA 2 0.0013
174 TEMPERATURE REGULATION DISORDER 3 0.0013
175 AXILLARY PAIN 2 0.0013
176 LARGE INTESTINAL OBSTRUCTION 3 0.0013
177 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
178 POLYARTHRITIS 7 0.0013
179 PERIARTHRITIS 3 0.0013
180 HYPERTHERMIA 10 0.0013
181 INFUSION SITE INFECTION 3 0.0013
182 SINUS PAIN 3 0.0013
183 URINARY INCONTINENCE 38 0.0013
184 NONSPECIFIC REACTION 7 0.0013
185 MYOPIA 3 0.0013
186 TRIGEMINAL NEURALGIA 5 0.0012
187 CYSTITIS INTERSTITIAL 2 0.0012
188 NEUROLOGICAL SYMPTOM 7 0.0012
189 LISTLESS 4 0.0012
190 ACUTE CORONARY SYNDROME 10 0.0012
191 BLOOD CALCIUM ABNORMAL 2 0.0012
192 VASODILATATION 3 0.0012
193 DECREASED INTEREST 7 0.0012
194 PARKINSON'S DISEASE 3 0.0012
195 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
196 BLADDER NEOPLASM 2 0.0012
197 EJECTION FRACTION DECREASED 18 0.0012
198 CARDIOVASCULAR DISORDER 29 0.0011
199 INFUSION SITE DISCHARGE 2 0.0011
200 LUNG OPACITY 3 0.0011
201 ORAL HERPES 22 0.0011
202 AREFLEXIA 3 0.0011
203 WHITE BLOOD CELL DISORDER 3 0.0011
204 SHOCK HAEMORRHAGIC 9 0.0011
205 ESSENTIAL HYPERTENSION 2 0.0011
206 NOCTURIA 13 0.0011
207 SNORING 4 0.0011
208 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
209 BILE DUCT OBSTRUCTION 2 0.0011
210 INJECTION SITE SCAR 3 0.0011
211 TROPONIN INCREASED 8 0.0011
212 MICTURITION URGENCY 12 0.0010
213 EMERGENCY CARE 3 0.0010
214 MUSCLE TIGHTNESS 16 0.0010
215 BREAST DISORDER 2 0.0010
216 MASTICATION DISORDER 3 0.0010
217 DYSAESTHESIA 3 0.0010
218 SPINAL STENOSIS 4 0.0010
219 CATHETER SITE ERYTHEMA 2 0.0009
220 INFUSION SITE BRUISING 2 0.0009
221 IMPAIRED HEALING 30 0.0009
222 HAEMATURIA 31 0.0009
223 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
224 MULTIPLE ALLERGIES 7 0.0009
225 PERIPHERAL COLDNESS 12 0.0009
226 EYELID DISORDER 2 0.0009
227 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
228 HEPATIC CYTOLYSIS 11 0.0009
229 ESCHERICHIA BACTERAEMIA 2 0.0008
230 BRADYKINESIA 5 0.0008
231 GLOSSITIS 3 0.0008
232 COLITIS MICROSCOPIC 4 0.0008
233 HYPERKALAEMIA 29 0.0008
234 URINARY TRACT INFECTION 141 0.0008
235 VITAMIN D DEFICIENCY 8 0.0008
236 PHARYNGEAL SWELLING 8 0.0008
237 HYPONATRAEMIA 46 0.0008
238 SCIATICA 13 0.0008
239 CARTILAGE INJURY 2 0.0008
240 PRE-EXISTING CONDITION IMPROVED 5 0.0008
241 EMPHYSEMA 8 0.0008
242 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
243 MENTAL IMPAIRMENT 19 0.0008
244 THYROID MASS 3 0.0008
245 MYDRIASIS 10 0.0008
246 REHABILITATION THERAPY 3 0.0008
247 RENAL CYST 6 0.0008
248 DEMENTIA 21 0.0008
249 OBSTRUCTION 3 0.0008
250 SENSORY DISTURBANCE 12 0.0007
251 FLANK PAIN 7 0.0007
252 ARTERIOSCLEROSIS 7 0.0007
253 BURSITIS 9 0.0007
254 ERECTILE DYSFUNCTION 19 0.0007
255 LYMPHOCYTE COUNT DECREASED 13 0.0007
256 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
257 DERMATITIS ALLERGIC 9 0.0007
258 DRUG TOLERANCE DECREASED 2 0.0007
259 EJACULATION DISORDER 2 0.0007
260 DRY MOUTH 57 0.0007
261 PRODUCT DISPENSING ISSUE 3 0.0007
262 HYPERTONIA 4 0.0007
263 POLLAKIURIA 29 0.0007
264 TOXIC SKIN ERUPTION 7 0.0007
265 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
266 WHEELCHAIR USER 3 0.0007
267 ILEUS PARALYTIC 3 0.0007
268 QUALITY OF LIFE DECREASED 9 0.0007
269 INFUSION SITE REACTION 2 0.0007
270 GASTROINTESTINAL INFECTION 6 0.0007
271 LOSS OF LIBIDO 6 0.0007
272 LUMBAR VERTEBRAL FRACTURE 3 0.0007
273 FACE OEDEMA 11 0.0007
274 SYNOVIAL CYST 3 0.0006
275 DIASTOLIC DYSFUNCTION 2 0.0006
276 TIBIA FRACTURE 3 0.0006
277 SKIN ABRASION 3 0.0006
278 HALLUCINATION 47 0.0006
279 INFUSION SITE PAIN 8 0.0006
280 HYPOKINESIA 9 0.0006
281 HAEMATOMA 16 0.0006
282 NEURALGIA 15 0.0006
283 INCORRECT DOSAGE ADMINISTERED 3 0.0006
284 MUSCLE TWITCHING 14 0.0006
285 DIABETIC NEUROPATHY 3 0.0006
286 BLADDER DISORDER 6 0.0006
287 CYTOLYTIC HEPATITIS 2 0.0006
288 SKIN MASS 4 0.0006
289 ERYSIPELAS 3 0.0006
290 DYSKINESIA 24 0.0006
291 ATAXIA 7 0.0006
292 IMPAIRED GASTRIC EMPTYING 8 0.0006
293 SCAR 10 0.0006
294 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
295 CERVICAL VERTEBRAL FRACTURE 2 0.0006
296 BLOOD CREATININE ABNORMAL 2 0.0006
297 CAROTID ARTERY STENOSIS 2 0.0006
298 HALLUCINATION, VISUAL 12 0.0006
299 DEPRESSIVE SYMPTOM 2 0.0006
300 NEPHROLITHIASIS 26 0.0006
301 JAUNDICE CHOLESTATIC 2 0.0006
302 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
303 HAEMORRHAGIC DIATHESIS 2 0.0006
304 NEUTROPENIC SEPSIS 4 0.0006
305 ANAL INCONTINENCE 5 0.0006
306 FALL 185 0.0006
307 MULTIPLE SCLEROSIS RELAPSE 38 0.0006
308 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
309 FAECES SOFT 4 0.0005
310 CHOKING SENSATION 3 0.0005
311 GASTRIC ULCER HAEMORRHAGE 3 0.0005
312 HEART RATE ABNORMAL 3 0.0005
313 CARDIAC DYSFUNCTION 2 0.0005
314 ORAL PAIN 12 0.0005
315 COGNITIVE DISORDER 25 0.0005
316 IMPULSIVE BEHAVIOUR 2 0.0005
317 PERONEAL NERVE PALSY 3 0.0005
318 COMMUNICATION DISORDER 2 0.0005
319 GASTRIC INFECTION 2 0.0005
320 HERPES ZOSTER 30 0.0005
321 EXERCISE TOLERANCE DECREASED 3 0.0005
322 MOUTH SWELLING 3 0.0005
323 OSTEOARTHRITIS 22 0.0005
324 HAEMOLYSIS 4 0.0005
325 DYSURIA 19 0.0005
326 VASCULITIS 6 0.0005
327 DELUSION 8 0.0005
328 FAECES HARD 2 0.0005
329 GAIT DISTURBANCE 98 0.0005
330 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
331 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
332 HOSPICE CARE 5 0.0005
333 HYPERLIPIDAEMIA 6 0.0005
334 MUSCLE RIGIDITY 6 0.0005
335 SYMPTOM RECURRENCE 3 0.0005
336 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
337 CANDIDIASIS 2 0.0005
338 CYTOKINE RELEASE SYNDROME 10 0.0005
339 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
340 FUNGAL SKIN INFECTION 2 0.0005
341 PRODUCT ADMINISTRATION ERROR 10 0.0005
342 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
343 INGUINAL HERNIA 3 0.0005
344 DRY THROAT 5 0.0005
345 DECUBITUS ULCER 4 0.0005
346 GOITRE 2 0.0005
347 HICCUPS 4 0.0005
348 RIB FRACTURE 10 0.0005
349 AGRANULOCYTOSIS 9 0.0005
350 MUSCULAR WEAKNESS 55 0.0005
351 INFUSION SITE SWELLING 3 0.0005
352 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
353 INFUSION SITE ERYTHEMA 4 0.0005
354 FULL BLOOD COUNT ABNORMAL 5 0.0005
355 CARDIAC FAILURE CHRONIC 2 0.0005
356 VITAMIN D DECREASED 4 0.0005
357 INCOHERENT 3 0.0005
358 LACTIC ACIDOSIS 15 0.0005
359 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
360 MUCOSAL INFLAMMATION 12 0.0005
361 CHOLELITHIASIS 15 0.0005
362 DYSPEPSIA 45 0.0005
363 IMMUNOSUPPRESSION 4 0.0005
364 OEDEMA PERIPHERAL 55 0.0005
365 MYOSITIS 4 0.0004
366 SKIN INFECTION 5 0.0004
367 DISTURBANCE IN ATTENTION 24 0.0004
368 RESTLESS LEGS SYNDROME 8 0.0004
369 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
370 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
371 ABDOMINAL HERNIA 2 0.0004
372 SEPTIC SHOCK 19 0.0004
373 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
374 MYOCARDITIS 5 0.0004
375 ONYCHOCLASIS 3 0.0004
376 PLASMA CELL MYELOMA 17 0.0004
377 LYMPHOEDEMA 3 0.0004
378 UROSEPSIS 4 0.0004
379 NERVE COMPRESSION 4 0.0004
380 IRON DEFICIENCY ANAEMIA 4 0.0004
381 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
382 COORDINATION ABNORMAL 6 0.0004
383 THERAPY CESSATION 22 0.0004
384 RIGHT VENTRICULAR FAILURE 3 0.0004
385 PAPULE 3 0.0004
386 SEASONAL ALLERGY 6 0.0004
387 RESPIRATORY TRACT INFECTION 11 0.0004
388 DIVERTICULUM 3 0.0004
389 LIMB DISCOMFORT 13 0.0004
390 MULTIPLE SCLEROSIS 20 0.0004
391 CHOLESTASIS 8 0.0004
392 DERMATITIS BULLOUS 3 0.0004
393 ENTEROCOCCAL INFECTION 2 0.0004
394 SINUS BRADYCARDIA 4 0.0004
395 INJECTION SITE HAEMATOMA 6 0.0004
396 HEMIPARESIS 7 0.0004
397 MAJOR DEPRESSION 3 0.0004
398 AUTOIMMUNE DISORDER 4 0.0004
399 RESTLESSNESS 15 0.0004
400 CYSTITIS 13 0.0004
401 COELIAC DISEASE 4 0.0004
402 SMALL INTESTINAL OBSTRUCTION 5 0.0004
403 BREATH SOUNDS ABNORMAL 2 0.0004
404 ARTHROPOD BITE 3 0.0004
405 HYPERVOLAEMIA 2 0.0004
406 LIGAMENT SPRAIN 4 0.0004
407 DISORIENTATION 16 0.0004
408 HEPATIC ENZYME ABNORMAL 2 0.0004
409 SECRETION DISCHARGE 5 0.0004
410 CHROMATURIA 9 0.0004
411 CONFUSIONAL STATE 64 0.0004
412 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
413 HAEMODYNAMIC INSTABILITY 3 0.0004
414 BALANCE DISORDER 34 0.0004
415 MOTOR DYSFUNCTION 4 0.0004
416 SLUGGISHNESS 4 0.0004
417 ACUTE KIDNEY INJURY 60 0.0004
418 HYPOGLYCAEMIA 19 0.0004
419 EUPHORIC MOOD 4 0.0004
420 FEMORAL NECK FRACTURE 2 0.0004
421 RENAL FAILURE CHRONIC 3 0.0004
422 MOBILITY DECREASED 28 0.0004
423 INCREASED UPPER AIRWAY SECRETION 2 0.0004
424 FOOD ALLERGY 3 0.0004
425 TEMPERATURE INTOLERANCE 4 0.0004
426 UNRESPONSIVE TO STIMULI 10 0.0004
427 APNOEA 3 0.0004
428 FAILURE TO THRIVE 2 0.0004
429 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
430 CATATONIA 2 0.0004
431 TOOTH INFECTION 5 0.0004
432 DYSPHONIA 22 0.0004
433 EAR INFECTION 10 0.0004
434 FEELING HOT 23 0.0004
435 FOOD POISONING 2 0.0004
436 MALIGNANT MELANOMA 5 0.0004
437 ANAL ABSCESS 2 0.0004
438 HIP SURGERY 2 0.0004
439 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
440 FAECES DISCOLOURED 8 0.0004
441 BLOOD URINE PRESENT 7 0.0004
442 SKIN LACERATION 4 0.0004
443 PRODUCT PRESCRIBING ISSUE 8 0.0004
444 CONSTIPATION 80 0.0004
445 OESOPHAGITIS 4 0.0004
446 ASPIRATION 4 0.0004
447 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
448 HYPERKERATOSIS 2 0.0004
449 FEBRILE NEUTROPENIA 24 0.0004
450 ANAEMIA 69 0.0004
451 PRESCRIBED OVERDOSE 7 0.0004
452 SINUSITIS 37 0.0004
453 SENSATION OF FOREIGN BODY 3 0.0004
454 BLOOD TEST ABNORMAL 5 0.0004
455 RASH ERYTHEMATOUS 17 0.0004
456 LYMPHOPENIA 5 0.0004
457 BLOOD PRESSURE ABNORMAL 7 0.0004
458 PSYCHOLOGICAL TRAUMA 3 0.0003
459 HYSTERECTOMY 3 0.0003
460 TREMOR 57 0.0003
461 BODY TEMPERATURE INCREASED 7 0.0003
462 DYSSTASIA 10 0.0003
463 BLOOD CALCIUM INCREASED 3 0.0003
464 HYPERTRIGLYCERIDAEMIA 2 0.0003
465 SPINAL OSTEOARTHRITIS 3 0.0003
466 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
467 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
468 HEAD DISCOMFORT 6 0.0003
469 ATRIAL FIBRILLATION 33 0.0003
470 COVID-19 PNEUMONIA 4 0.0003
471 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
472 COVID-19 59 0.0003
473 APHASIA 10 0.0003
474 EPILEPSY 10 0.0003
475 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
476 SLEEP DISORDER 23 0.0003
477 BLOOD GLUCOSE ABNORMAL 6 0.0003
478 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
479 INJECTION SITE DISCOLOURATION 4 0.0003
480 SYNCOPE 32 0.0003
481 DYSARTHRIA 12 0.0003
482 HOT FLUSH 24 0.0003
483 BLEPHAROSPASM 2 0.0003
484 SPUTUM DISCOLOURED 3 0.0003
485 FOREIGN BODY SENSATION IN EYES 2 0.0003
486 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
487 VERTIGO 19 0.0003
488 INJECTION SITE INDURATION 4 0.0003
489 ASTHENIA 116 0.0003
490 PARKINSONISM 3 0.0003
491 HAEMORRHOIDS 6 0.0003
492 PERIPHERAL SWELLING 47 0.0003
493 ASPERGILLUS INFECTION 2 0.0003
494 DYSGRAPHIA 2 0.0003
495 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
496 APPETITE DISORDER 2 0.0003
497 UPPER LIMB FRACTURE 6 0.0003
498 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
499 SINUS CONGESTION 4 0.0003
500 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
501 TACHYPNOEA 4 0.0003
502 PRODUCT PRESCRIBING ERROR 7 0.0003
503 ABNORMAL LOSS OF WEIGHT 2 0.0003
504 BLOOD TESTOSTERONE DECREASED 2 0.0003
505 MYOCARDIAL INFARCTION 51 0.0003
506 COLITIS 11 0.0003
507 DELIRIUM 10 0.0003
508 ORAL DISCOMFORT 4 0.0003
509 ORTHOSTATIC HYPOTENSION 5 0.0003
510 SEPSIS 32 0.0003
511 EXTRASYSTOLES 2 0.0003
512 HEAD INJURY 9 0.0003
513 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
514 PNEUMONIA ASPIRATION 7 0.0003
515 LEUKOPENIA 14 0.0003
516 DECREASED APPETITE 65 0.0003
517 POOR QUALITY SLEEP 6 0.0003
518 RHINORRHOEA 18 0.0003
519 DEHYDRATION 37 0.0003
520 DRUG INTERACTION 44 0.0003
521 VISION BLURRED 38 0.0003
522 MEMORY IMPAIRMENT 38 0.0003
523 HAEMATEMESIS 7 0.0003
524 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
525 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
526 GASTROENTERITIS 4 0.0003
527 HYPOAESTHESIA 41 0.0003
528 INTENTIONAL UNDERDOSE 2 0.0003
529 ACCIDENTAL OVERDOSE 10 0.0003
530 DENTAL CARIES 3 0.0003
531 BURNING SENSATION 19 0.0003
532 CEREBRAL DISORDER 2 0.0003
533 TACHYCARDIA 24 0.0003
534 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
535 SKIN HAEMORRHAGE 4 0.0003
536 RASH MACULO-PAPULAR 6 0.0003
537 THROAT IRRITATION 12 0.0003
538 GENERAL SYMPTOM 2 0.0003
539 FRACTURE 5 0.0003
540 DERMATITIS CONTACT 3 0.0003
541 MUSCULOSKELETAL DISORDER 5 0.0003
542 INTERNAL HAEMORRHAGE 3 0.0003
543 ABDOMINAL DISCOMFORT 44 0.0003
544 SLEEP APNOEA SYNDROME 5 0.0003
545 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
546 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
547 DRY EYE 13 0.0003
548 RENAL FAILURE ACUTE 11 0.0003
549 ATRIOVENTRICULAR BLOCK 2 0.0003
550 MUSCULOSKELETAL CHEST PAIN 4 0.0003
551 ELECTROLYTE IMBALANCE 3 0.0003
552 PALLOR 7 0.0003
553 ACUTE MYELOID LEUKAEMIA 4 0.0003
554 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
555 PRODUCT USE COMPLAINT 4 0.0003
556 ARRHYTHMIA 12 0.0003
557 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
558 BLOOD IRON DECREASED 3 0.0003
559 HEART RATE INCREASED 25 0.0003
560 HAEMATOCRIT DECREASED 5 0.0003
561 BLOOD ALBUMIN DECREASED 2 0.0003
562 HALLUCINATION, AUDITORY 4 0.0003
563 FEELING COLD 7 0.0003
564 GINGIVAL PAIN 2 0.0003
565 MACULAR DEGENERATION 3 0.0003
566 ATRIAL FLUTTER 2 0.0003
567 WRIST FRACTURE 3 0.0003
568 HYPERTENSION 53 0.0002
569 SPINAL FRACTURE 5 0.0002
570 FULL BLOOD COUNT DECREASED 5 0.0002
571 SPEECH DISORDER 13 0.0002
572 C-REACTIVE PROTEIN INCREASED 9 0.0002
573 PRESYNCOPE 6 0.0002
574 FEEDING DISORDER 5 0.0002
575 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
576 BRADYCARDIA 13 0.0002
577 SPINAL OPERATION 3 0.0002
578 MANIA 4 0.0002
579 OSTEOPOROSIS 10 0.0002
580 HAIR DISORDER 2 0.0002
581 LOSS OF CONSCIOUSNESS 31 0.0002
582 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
583 LIVER FUNCTION TEST ABNORMAL 7 0.0002
584 HEMIPLEGIA 2 0.0002
585 BREAST CANCER STAGE II 2 0.0002
586 FUNGAL INFECTION 8 0.0002
587 PALPITATIONS 28 0.0002
588 DYSPNOEA EXERTIONAL 9 0.0002
589 KNEE ARTHROPLASTY 5 0.0002
590 ABDOMINAL PAIN LOWER 6 0.0002
591 MUSCLE ATROPHY 3 0.0002
592 CIRCULATORY COLLAPSE 4 0.0002
593 EATING DISORDER 5 0.0002
594 HEPATITIS 6 0.0002
595 ROTATOR CUFF SYNDROME 3 0.0002
596 GASTRIC DISORDER 8 0.0002
597 CARDIAC OPERATION 2 0.0002
598 COUGH 65 0.0002
599 BLOOD MAGNESIUM DECREASED 2 0.0002
600 SUICIDE ATTEMPT 14 0.0002
601 PRODUCTIVE COUGH 11 0.0002
602 DEVICE DISLOCATION 10 0.0002
603 DEPRESSION 52 0.0002
604 GRIP STRENGTH DECREASED 2 0.0002
605 HYPOXIA 8 0.0002
606 ABNORMAL BEHAVIOUR 9 0.0002
607 OROPHARYNGEAL PAIN 21 0.0002
608 ARTHRALGIA 94 0.0002
609 LYMPHADENOPATHY 8 0.0002
610 TRANSAMINASES INCREASED 5 0.0002
611 EYE HAEMORRHAGE 3 0.0002
612 SWOLLEN TONGUE 7 0.0002
613 GALLBLADDER DISORDER 4 0.0002
614 FACIAL PAIN 2 0.0002
615 THIRST 4 0.0002
616 SOMNOLENCE 45 0.0002
617 PULMONARY OEDEMA 10 0.0002
618 ILLNESS 23 0.0002
619 GASTROINTESTINAL DISORDER 20 0.0002
620 RASH PAPULAR 5 0.0002
621 GASTROENTERITIS VIRAL 4 0.0002
622 AKATHISIA 3 0.0002
623 GINGIVAL BLEEDING 3 0.0002
624 END STAGE RENAL DISEASE 4 0.0002
625 EXOSTOSIS 2 0.0002
626 MOVEMENT DISORDER 7 0.0002
627 MUSCLE SPASMS 40 0.0002
628 SHOCK 5 0.0002
629 INCREASED TENDENCY TO BRUISE 2 0.0002
630 GRAND MAL CONVULSION 2 0.0002
631 DIVERTICULITIS 6 0.0002
632 CONJUNCTIVITIS 4 0.0002
633 NECK PAIN 12 0.0002
634 DIZZINESS 107 0.0002
635 BLOOD CHOLESTEROL INCREASED 10 0.0002
636 HYPOTENSION 43 0.0002
637 CARPAL TUNNEL SYNDROME 3 0.0002
638 MIDDLE INSOMNIA 4 0.0002
639 APPENDICITIS 2 0.0002
640 PAIN IN EXTREMITY 63 0.0002
641 BLISTER 12 0.0002
642 DEVICE OCCLUSION 3 0.0002
643 INFLAMMATION 11 0.0002
644 PHOTOPHOBIA 4 0.0002
645 LACERATION 2 0.0002
646 FLATULENCE 12 0.0002
647 FOOT FRACTURE 4 0.0002
648 FATIGUE 164 0.0002
649 MUSCULOSKELETAL PAIN 11 0.0002
650 RED BLOOD CELL COUNT DECREASED 6 0.0002
651 DRY SKIN 28 0.0002
652 HYPERHIDROSIS 27 0.0002
653 PARALYSIS 3 0.0002
654 SUBDURAL HAEMATOMA 3 0.0002
655 GAIT INABILITY 7 0.0002
656 HYPERSOMNIA 6 0.0002
657 ALOPECIA 41 0.0002
658 IMPAIRED QUALITY OF LIFE 3 0.0002
659 PULMONARY FIBROSIS 4 0.0002
660 EYE PRURITUS 7 0.0002
661 ACUTE RESPIRATORY FAILURE 4 0.0002
662 CONTUSION 20 0.0002
663 HYPERCHOLESTEROLAEMIA 2 0.0002
664 DYSPNOEA 117 0.0002
665 INFLUENZA 23 0.0002
666 MUSCULOSKELETAL STIFFNESS 18 0.0002
667 CHOKING 4 0.0002
668 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
669 LIVER INJURY 5 0.0002
670 HEPATOMEGALY 2 0.0002
671 KNEE OPERATION 2 0.0002
672 SWELLING 19 0.0002
673 BLOOD PRESSURE INCREASED 31 0.0002
674 INABILITY TO AFFORD MEDICATION 2 0.0002
675 IMMUNODEFICIENCY 3 0.0002
676 TREATMENT NONCOMPLIANCE 11 0.0002
677 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
678 PULMONARY EMBOLISM 19 0.0002
679 BLOOD POTASSIUM DECREASED 6 0.0002
680 HEART RATE DECREASED 7 0.0002
681 CELLULITIS 10 0.0002
682 ECONOMIC PROBLEM 3 0.0002
683 HYPOTHERMIA 2 0.0002
684 TASTE DISORDER 4 0.0002
685 EYELID PTOSIS 2 0.0002
686 THROMBOCYTOPENIA 22 0.0002
687 OXYGEN SATURATION DECREASED 11 0.0002
688 HYPOPHAGIA 5 0.0002
689 HYPOKALAEMIA 9 0.0002
690 INITIAL INSOMNIA 2 0.0002
691 THYROID DISORDER 3 0.0002
692 TENDONITIS 3 0.0002
693 FEMUR FRACTURE 6 0.0002
694 DIPLOPIA 5 0.0002
695 RHABDOMYOLYSIS 8 0.0002
696 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
697 ABDOMINAL DISTENSION 20 0.0002
698 DRUG-INDUCED LIVER INJURY 6 0.0002
699 LETHARGY 11 0.0002
700 AGITATION 14 0.0002
701 BACK PAIN 44 0.0002
702 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
703 VOMITING 89 0.0002
704 DEPRESSED MOOD 10 0.0002
705 BRONCHITIS 14 0.0002
706 COMA 9 0.0002
707 RESPIRATORY TRACT CONGESTION 3 0.0002
708 CHILLS 22 0.0002
709 FLUSHING 19 0.0002
710 CARDIAC FAILURE 15 0.0002
711 HEREDITARY ANGIOEDEMA 2 0.0002
712 DECREASED ACTIVITY 2 0.0002
713 CATARACT 11 0.0002
714 AMNESIA 12 0.0002
715 PRODUCT DOSE OMISSION 12 0.0002
716 BLOOD CREATININE INCREASED 12 0.0002
717 WEIGHT DECREASED 51 0.0002
718 HEADACHE 114 0.0002
719 GASTROINTESTINAL PAIN 2 0.0002
720 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
721 INSOMNIA 48 0.0002
722 ARTHROPATHY 10 0.0002
723 HYPERTENSIVE CRISIS 2 0.0002
724 BLOOD UREA INCREASED 3 0.0002
725 DYSPHAGIA 17 0.0002
726 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
727 TYPE 2 DIABETES MELLITUS 6 0.0002
728 BLOOD CALCIUM DECREASED 2 0.0002
729 MALAISE 78 0.0002
730 EYE PAIN 10 0.0002
731 HEART RATE IRREGULAR 4 0.0002
732 FLUID RETENTION 9 0.0002
733 ANGINA PECTORIS 5 0.0002
734 PRURITUS 67 0.0002
735 SKIN DISCOLOURATION 8 0.0002
736 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
737 RENAL FAILURE 23 0.0002
738 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
739 RENAL DISORDER 8 0.0002
740 RASH MACULAR 6 0.0002
741 SURGERY 10 0.0002
742 COLD SWEAT 3 0.0002
743 INFLUENZA LIKE ILLNESS 14 0.0002
744 VISUAL IMPAIRMENT 21 0.0002
745 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
746 LEUKOCYTOSIS 3 0.0002
747 HEPATITIS C 2 0.0002
748 LACRIMATION INCREASED 5 0.0002
749 ANXIETY 47 0.0002
750 ABDOMINAL PAIN UPPER 34 0.0002
751 DISCOMFORT 10 0.0002
752 CEREBRAL INFARCTION 4 0.0002
753 HYPERCALCAEMIA 2 0.0002
754 HEPATIC ENZYME INCREASED 11 0.0002
755 EXTRAPYRAMIDAL DISORDER 4 0.0002
756 HEPATIC STEATOSIS 3 0.0002
757 HAIR COLOUR CHANGES 2 0.0002
758 INFECTION 23 0.0002
759 PARAESTHESIA 25 0.0002
760 NEUROPATHY PERIPHERAL 15 0.0002
761 HYPOTHYROIDISM 5 0.0002
762 POST PROCEDURAL COMPLICATION 3 0.0002
763 HOSPITALISATION 24 0.0002
764 LOWER LIMB FRACTURE 3 0.0002
765 GLAUCOMA 3 0.0002
766 NIGHT SWEATS 5 0.0002
767 HERNIA 3 0.0002
768 DYSTONIA 3 0.0002
769 EAR PAIN 3 0.0002
770 SKIN FISSURES 3 0.0002
771 JOINT STIFFNESS 4 0.0002
772 BEDRIDDEN 2 0.0002
773 EYE DISORDER 5 0.0002
774 PAIN 93 0.0002
775 DYSMENORRHOEA 2 0.0002
776 ADVERSE REACTION 2 0.0002
777 BLOOD PRESSURE DECREASED 10 0.0002
778 PRESCRIBED UNDERDOSE 3 0.0002
779 PYREXIA 52 0.0002
780 DIARRHOEA 97 0.0002
781 BREAST CANCER FEMALE 4 0.0001
782 LIMB INJURY 4 0.0001
783 SEIZURE 17 0.0001
784 ABDOMINAL PAIN 34 0.0001
785 INJECTION SITE WARMTH 3 0.0001
786 SKIN LESION 4 0.0001
787 CHEST PAIN 27 0.0001
788 TOOTH LOSS 3 0.0001
789 INTERSTITIAL LUNG DISEASE 7 0.0001
790 NIGHTMARE 5 0.0001
791 APHONIA 2 0.0001
792 TOXICITY TO VARIOUS AGENTS 24 0.0001
793 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
794 PNEUMONIA 46 0.0001
795 SUICIDAL IDEATION 13 0.0001
796 FEELING ABNORMAL 34 0.0001
797 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
798 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
799 JOINT INJURY 3 0.0001
800 CONVULSION 8 0.0001
801 LIVER FUNCTION TEST INCREASED 3 0.0001
802 PRODUCT DOSE OMISSION ISSUE 41 0.0001
803 PRURITUS GENERALISED 3 0.0001
804 WEIGHT INCREASED 31 0.0001
805 DEVICE LEAKAGE 6 0.0001
806 SWELLING FACE 9 0.0001
807 HYPERTHYROIDISM 2 0.0001
808 PRODUCT DISPENSING ERROR 3 0.0001
809 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
810 NAUSEA 109 0.0001
811 DRUG EFFECT INCOMPLETE 5 0.0001
812 APATHY 2 0.0001
813 PSYCHOTIC DISORDER 4 0.0001
814 CONDITION AGGRAVATED 41 0.0001
815 HYPERSENSITIVITY 25 0.0001
816 NERVOUSNESS 7 0.0001
817 HAEMORRHAGE INTRACRANIAL 2 0.0001
818 RESPIRATORY DISORDER 4 0.0001
819 IRRITABILITY 8 0.0001
820 ASTHMA 15 0.0001
821 HEPATIC FAILURE 4 0.0001
822 INSURANCE ISSUE 2 0.0001
823 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
824 MYALGIA 22 0.0001
825 ANKLE FRACTURE 2 0.0001
826 RASH PRURITIC 7 0.0001
827 BASAL CELL CARCINOMA 2 0.0001
828 BRAIN FOG 2 0.0001
829 CYANOSIS 2 0.0001
830 CHEST DISCOMFORT 13 0.0001
831 HAEMATOCHEZIA 7 0.0001
832 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
833 ABSCESS 2 0.0001
834 BLOOD PRESSURE FLUCTUATION 3 0.0001
835 DIABETIC KETOACIDOSIS 3 0.0001
836 ABORTION SPONTANEOUS 5 0.0001
837 HIP FRACTURE 4 0.0001
838 JOINT SWELLING 15 0.0001
839 RESPIRATORY FAILURE 9 0.0001
840 RHEUMATOID ARTHRITIS 14 0.0001
841 BLOOD POTASSIUM INCREASED 2 0.0001
842 BACK DISORDER 2 0.0001
843 ABASIA 3 0.0001
844 STAPHYLOCOCCAL INFECTION 4 0.0001
845 EPISTAXIS 9 0.0001
846 AGEUSIA 3 0.0001
847 NASOPHARYNGITIS 22 0.0001
848 UNEVALUABLE EVENT 9 0.0001
849 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
850 CHRONIC KIDNEY DISEASE 9 0.0001
851 CANDIDA INFECTION 2 0.0001
852 DIABETES MELLITUS 9 0.0001
853 CEREBROVASCULAR ACCIDENT 20 0.0001
854 ERYTHEMA 24 0.0001
855 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
856 SKIN ULCER 3 0.0001
857 EXPOSURE VIA SKIN CONTACT 3 0.0001
858 STOMATITIS 7 0.0001
859 MENTAL DISORDER 5 0.0001
860 DEAFNESS 3 0.0001
861 EOSINOPHILIA 2 0.0001
862 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
863 DRUG ERUPTION 2 0.0001
864 PLATELET COUNT DECREASED 12 0.0001
865 JAUNDICE 3 0.0001
866 GOUT 2 0.0001
867 THROAT TIGHTNESS 3 0.0001
868 INTENTIONAL OVERDOSE 7 0.0001
869 CARDIAC ARREST 9 0.0001
870 PROCEDURAL PAIN 3 0.0001
871 MENTAL STATUS CHANGES 3 0.0001
872 HAEMOPTYSIS 3 0.0001
873 WOUND 3 0.0001
874 BACTERIAL INFECTION 2 0.0001
875 HAEMOGLOBIN DECREASED 11 0.0001
876 CARDIAC DISORDER 10 0.0001
877 TARDIVE DYSKINESIA 3 0.0001
878 OFF LABEL USE 93 0.0001
879 FEELING JITTERY 2 0.0001
880 MIGRAINE 10 0.0001
881 INJECTION SITE PRURITUS 7 0.0001
882 BLOOD GLUCOSE DECREASED 5 0.0001
883 NEEDLE ISSUE 3 0.0001
884 DRUG INEFFECTIVE 135 0.0001
885 NASAL CONGESTION 6 0.0001
886 LUNG DISORDER 5 0.0001
887 KIDNEY INFECTION 2 0.0001
888 ACUTE MYOCARDIAL INFARCTION 3 0.0001
889 ARTHRITIS 8 0.0001
890 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
891 DEVICE ISSUE 9 0.0001
892 AGGRESSION 5 0.0001
893 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
894 ILL-DEFINED DISORDER 6 0.0001
895 BONE MARROW FAILURE 2 0.0001
896 BLINDNESS 4 0.0001
897 EMOTIONAL DISORDER 3 0.0001
898 INCORRECT DOSE ADMINISTERED 22 0.0001
899 PRODUCT USE ISSUE 18 0.0001
900 NEUTROPENIA 13 0.0001
901 ECZEMA 5 0.0001
902 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
903 DYSGEUSIA 7 0.0001
904 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
905 METABOLIC ACIDOSIS 3 0.0001
906 IRRITABLE BOWEL SYNDROME 2 0.0001
907 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
908 OSTEONECROSIS 3 0.0001
909 EMOTIONAL DISTRESS 11 0.0001
910 LIVER DISORDER 4 0.0001
911 LIP SWELLING 3 0.0001
912 GLOSSODYNIA 2 0.0001
913 INJECTION SITE ERYTHEMA 11 0.0001
914 TINNITUS 4 0.0001
915 WHEEZING 5 0.0001
916 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
917 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
918 PLEURAL EFFUSION 5 0.0001
919 ENCEPHALOPATHY 2 0.0001
920 INJECTION SITE MASS 3 0.0001
921 EYE SWELLING 3 0.0001
922 RASH 35 0.0001
923 INTESTINAL OBSTRUCTION 3 0.0001
924 DEATH 68 0.0001
925 INJECTION SITE PAIN 24 0.0001
926 ANAPHYLACTIC SHOCK 2 0.0001
927 DEEP VEIN THROMBOSIS 5 0.0001
928 HAEMORRHAGE 8 0.0001
929 APPLICATION SITE ERYTHEMA 2 0.0001
930 GASTRITIS 2 0.0001
931 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
932 INJECTION SITE BRUISING 6 0.0001
933 EXTRA DOSE ADMINISTERED 3 0.0001
934 BLOOD BILIRUBIN INCREASED 2 0.0001
935 DEVICE BREAKAGE 3 0.0001
936 OEDEMA 4 0.0001
937 ABNORMAL DREAMS 2 0.0001
938 ROAD TRAFFIC ACCIDENT 3 0.0001
939 URTICARIA 12 0.0001
940 HYPOACUSIS 3 0.0001
941 EYE IRRITATION 4 0.0001
942 BLOOD GLUCOSE INCREASED 13 0.0001
943 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
944 ANGIOEDEMA 3 0.0001
945 THERAPY NON-RESPONDER 3 0.0001
946 THERAPEUTIC RESPONSE DECREASED 4 0.0001
947 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
948 INJECTION SITE SWELLING 5 0.0001
949 DRUG ADMINISTRATION ERROR 2 0.0001
950 OCULAR HYPERAEMIA 3 0.0001
951 DISEASE RECURRENCE 3 0.0001
952 CARDIAC FAILURE CONGESTIVE 5 0.0001
953 DRUG INTOLERANCE 6 0.0001
954 NO ADVERSE EVENT 11 0.0001
955 DEVICE DIFFICULT TO USE 4 0.0001
956 EXPIRED PRODUCT ADMINISTERED 2 0.0001
957 DRUG ABUSE 5 0.0001
958 SKIN EXFOLIATION 5 0.0001
959 ANGER 2 0.0001
960 DERMATITIS ATOPIC 3 0.0001
961 THERAPY INTERRUPTED 4 0.0001
962 ADVERSE DRUG REACTION 5 0.0001
963 CRYING 2 0.0001
964 UNDERDOSE 4 0.0001
965 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
966 ADVERSE EVENT 5 0.0001
967 PANCYTOPENIA 3 0.0001
968 ACNE 4 0.0001
969 PRODUCT SUBSTITUTION ISSUE 3 0.0001
970 BONE PAIN 3 0.0001
971 OVERDOSE 11 0.0001
972 DRUG DOSE OMISSION 8 0.0000
973 TREATMENT FAILURE 4 0.0000
974 CARDIO-RESPIRATORY ARREST 2 0.0000
975 RENAL IMPAIRMENT 4 0.0000
976 INTENTIONAL PRODUCT MISUSE 4 0.0000
977 COLITIS ULCERATIVE 2 0.0000
978 INJURY 3 0.0000
979 THROMBOSIS 3 0.0000
980 PRODUCT QUALITY ISSUE 5 0.0000
981 ANAPHYLACTIC REACTION 2 0.0000
982 PSORIASIS 4 0.0000
983 INFUSION RELATED REACTION 2 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
985 INJECTION SITE REACTION 2 0.0000
986 DISEASE PROGRESSION 3 0.0000
987 DRUG WITHDRAWAL SYNDROME 2 0.0000
988 BREAST CANCER 2 0.0000
989 DRUG DEPENDENCE 2 0.0000